Abstract
The relationship between the utilization of 3H-thymidine in situ ([3H]-TdR fractional incorporation or TFI) and tumour growth delay after treatment with various cytotoxic agents has been examined. It is shown that (a) it is not possible to predict tumour growth delay, or to select the most effective agent, from changes in TFI 1 day after treatment, (b) there is a good correlation between tumour growth delay and the time for recovery of TFI to the pretreatment level, (c) there is a relationship within a tumour line between the depression of TFI 4 days after treatment and growth dealy induced by the same treatment. This relationship appears to be independent of the mechanism by which the agent exerts its cytotoxic effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Houghton, P., Houghton, J. & Taylor, D. Effects of cytotoxic agents on TdR incorporation and growth delay in human colonic tumour xenografts. Br J Cancer 36, 206–214 (1977). https://doi.org/10.1038/bjc.1977.179
Issue Date:
DOI: https://doi.org/10.1038/bjc.1977.179
This article is cited by
-
Predictive tests in cancer chemotherapy a reappraisal
Klinische Wochenschrift (1984)